Literature DB >> 32594047

Hub genes and key pathways of traumatic brain injury: bioinformatics analysis and in vivo validation.

Yun-Liang Tang1, Long-Jun Fang1, Ling-Yang Zhong1, Jian Jiang1, Xiao-Yang Dong1, Zhen Feng1.   

Abstract

The exact mechanisms associated with secondary brain damage following traumatic brain injury (TBI) remain unclear; therefore, identifying the critical molecular mechanisms involved in TBI is essential. The mRNA expression microarray GSE2871 was downloaded from the Gene Expression Omnibus (GEO) repository. GSE2871 comprises a total of 31 cerebral cortex samples, including two post-TBI time points. The microarray features eight control and seven TBI samples, from 4 hours post-TBI, and eight control and eight TBI samples from 24 hours post-TBI. In this bioinformatics-based study, 109 and 66 differentially expressed genes (DEGs) were identified in a Sprague-Dawley (SD) rat TBI model, 4 and 24 hours post-TBI, respectively. Functional enrichment analysis showed that the identified DEGs were significantly enriched in several terms, such as positive regulation of nuclear factor-κB transcription factor activity, mitogen-activated protein kinase signaling pathway, negative regulation of apoptotic process, and tumor necrosis factor signaling pathway. Moreover, the hub genes with high connectivity degrees were primarily related to inflammatory mediators. To validate the top five hub genes, a rat model of TBI was established using the weight-drop method, and real-time quantitative polymerase chain reaction analysis of the cerebral cortex was performed. The results showed that compared with control rats, Tnf-α, c-Myc, Spp1, Cxcl10, Ptprc, Egf, Mmp9, and Lcn2 were upregulated, and Fn1 was downregulated in TBI rats. Among these hub genes, Fn1, c-Myc, and Ptprc may represent novel biomarkers or therapeutic targets for TBI. These identified pathways and key genes may provide insights into the molecular mechanisms of TBI and provide potential treatment targets for patients with TBI. This study was approved by the Experimental Animal Ethics Committee of the First Affiliated Hospital of Nanchang University, China (approval No. 003) in January 2016.

Entities:  

Keywords:  DEGs; Gene Ontology; Kyoto Encyclopedia of Genes and Genomes; bioinformatics; differentially expressed genes; hub genes; inflammation; molecular mechanism; traumatic brain injury

Year:  2020        PMID: 32594047     DOI: 10.4103/1673-5374.284996

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  8 in total

Review 1.  Traumatic MicroRNAs: Deconvolving the Signal After Severe Traumatic Brain Injury.

Authors:  Martin Cente; Katarina Matyasova; Nikoleta Csicsatkova; Adela Tomikova; Sara Porubska; Yun Niu; Marek Majdan; Peter Filipcik; Igor Jurisica
Journal:  Cell Mol Neurobiol       Date:  2022-07-19       Impact factor: 4.231

2.  Comparative transcriptomic analysis of rat versus mouse cerebral cortex after traumatic brain injury.

Authors:  Meng-Shi Yang; Xiao-Jian Xu; Bin Zhang; Fei Niu; Bai-Yun Liu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

Review 3.  Insights into nervous system repair from the fruit fly.

Authors:  David Coupe; Torsten Bossing
Journal:  Neuronal Signal       Date:  2022-04-13

4.  Batroxobin inhibits astrocyte activation following nigrostriatal pathway injury.

Authors:  Zhuo Zhang; Xue Bao; Dan Li
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

5.  Alterations of microRNAs expression profiles in small extracellular vesicle after traumatic brain injury in mice.

Authors:  Ye Tian; Ruiting Zhao; Xiaochun Li; Ju Zhou; Daqiang Zhan; Yuanzhi Wang; Yifan He; Jiacheng Zhang; Hengjie Yuan
Journal:  Exp Anim       Date:  2022-03-07

6.  Potential Progression Mechanism and Key Genes in Early Stage of mTBI.

Authors:  Hu Zhou; Xue Han; Hui-Xia Zhou; Zhen-Zhen Cao; Li Yang; Jian-Yun Yu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

7.  Low-intensity focused ultrasound attenuates early traumatic brain injury by OX-A/NF-κB/NLRP3 signaling pathway.

Authors:  Lianghua Huang; Junwei Kang; Gengfa Chen; Wen Ye; Xiangqiang Meng; Qing Du; Zhen Feng
Journal:  Aging (Albany NY)       Date:  2022-09-16       Impact factor: 5.955

8.  Linalool inhibits the growth of human T cell acute lymphoblastic leukemia cells with involvement of the MAPK signaling pathway.

Authors:  Xubo Gong; Baiyong Wang; Lijuan Yan; Xiaoya Lu; Xiaoying Zhao
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.